| Ustekinumab (Stelara)                       | Every 12 weeks                               | Week 13                                                       |
| Ixekizumab (Taltz)†                         | Every 4 weeks                                | Week 5                                                        |
| IL-23 Guselkumab (Tremfya)†                 | Every 8 weeks                                | Week 9                                                        |